What Bioptická laboratoř does

Bioptická laboratoř s.r.o., founded in 2004 in Plzeň, Czech Republic, is the largest cytological and histopathological laboratory in the Czech Republic and one of the largest such facilities in Europe. The company operates an integrated diagnostic platform spanning cytology (Liquid Based Cytology augmented with the Hologic Genius AI system), biopsy interpretation (including IBEX AI for prostate biopsies), immunohistochemistry, HPV testing (Digene Hybrid Capture 2 and InnoLiPA), and molecular genetics/microbiology — processing approximately 1,000,000 cytology examinations, 200,000 biopsy samples, and 60,000+ genetic and molecular-pathology tests per year. It is one of only five Czech labs authorized by the Ministry of Health for cervical cancer screening cytology, holds ČSN EN ISO 15189 accreditation with a flexible scope for immunohistochemistry, and is the only Czech laboratory operating both an ICDP-UEMS Specialty Training Centre in Dermatopathology (accredited 2012) and an ESP Giordano Fellowship Genitourinary Pathology Training Centre (accredited 2015).

The business operates a hybrid revenue model: core diagnostic volumes are billed to Czech public health insurers under national screening and routine care contracts, while a growing self-pay channel (ZjistiCoTiJe.cz e-commerce storefront launched August 2025, Panorama NIPT, hereditary cancer panels, HPV genotyping) serves consumers directly. A separate professional services revenue stream comes from EU-accredited specialty training programs, recurring pathology conferences (Biopticka Multihead Tuesdays, KTF, BST, AMR symposia, dermatopathology summer schools), and authored monographs (Cutaneous Adnexal Tumors — Wolters Kluwer/LWW 2013; Nádory varlat — 2026). Go-to-market is sales-led for Czech clinicians (call-center hotlines per service line, free sample-collection kit delivery, WebZIS online portal, partner-gynecologist directory at gynekolog.cz), community-led for international trainees via the two EU-accredited training centers, and direct-to-consumer via the 2025 self-pay storefront. The customer base spans Czech gynecologists, dermatovenerologists, urologists, hospital pathology departments, self-pay patients, and international pathology trainees — anchored by a leadership team that includes internationally recognized Czech pathologists.

The company has no disclosed parent, no institutional investors, and is privately held as a Czech s.r.o. Recent strategic moves include the 2024 deployment of Hologic Genius AI and IBEX AI for clinical workflows, the 2025 launch of direct-to-consumer e-commerce, and the June 2026 AIxMed (Taiwan) memorandum on co-development of further AI diagnostic programs — collectively indicating an offensive push into AI-differentiated diagnostics and adjacent self-pay verticals while leveraging an entrenched Czech B2B referral base.

Name

Bioptická laboratoř

Legal name

Bioptická laboratoř s.r.o.

Website

https://biopticka.cz

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Bioptická laboratoř s.r.o. is the largest cytological and histopathological laboratory in the Czech Republic, providing AI-augmented cytology, biopsy, immunohistochemistry, HPV testing, and molecular genetics diagnostics to Czech physicians, hospitals, self-pay patients, and international pathology trainees, with ~1M cytologies and 200k biopsies processed annually.

Ownership category

akta.pro rank

Product category

Pathology Diagnostic Services

NAICS

Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)

akta.pro primary industry

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

akta.pro secondary industries

Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays) (HLAAALAI), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Lab Data Exchange & Interoperability (HL7/FHIR/LDT Results Delivery) (HLACAMAL), Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN)

Keywords

• Pathology diagnostic services
• Clinical laboratory testing
• Molecular genetic diagnostics
• Cytology screening
• Dermatopathology diagnostics

Headquarters

HQ city

Plzen

HQ country

Czechia

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Health-insurance-reimbursed diagnostic services: Core revenue stream: biopsy, cytology, HPV testing, immunohistochemistry, molecular genetic testing and other diagnostics billed to Czech public health insurers (one of only 5 cytology labs accredited by the Czech Ministry of Health for cervical cancer screening).
2. Self-pay (samoplátce) diagnostic testing: Direct-payment examinations including HPV genotyping (InnoLiPA), Panorama NIPT, genetic cancer predisposition testing, SARS-CoV-2 PCR/antigen/antibody testing for travelers, and the broader ZjistiCoTiJe.cz self-order channel launched in 2025.
3. Professional education & training programs: Revenue from ICDP-UEMS Dermatopathology Training Center (accredited 2012), ESP Genitourinary Pathology "Giordano Fellowship" Training Center (accredited 2015), international multihead-microscope courses (BST 2025, KTF, AMR Slide Symposium), ESF-funded vocational courses, and weekly Biopticka Multihead Tuesdays.
4. Monograph and scientific publication sales: Sales of authored monographs such as "Cutaneous Adnexal Tumors" (Wolters Kluwer/LWW, 814 pp., co-authored with P.H. McKee) and the 2026 monograph "Nádory varlat" (priced at 599 CZK).
5. Conference & event sponsorship: Sponsored scientific congresses (e.g., EBMWG 2019) and pathology meetings with industry partners (BioTech, Baria, Altium listed for BST 2025).

Pricing tiers

Go-to-market motion4 records

Distribution channels6 records

Marketing channels8 records

Core offering

Bioptická laboratoř s.r.o. operates the largest cytological and histopathological laboratory in the Czech Republic, providing integrated diagnostic services across cytology, biopsy, immunohistochemistry, molecular genetics, dermatopathology, and HPV testing. The lab processes approximately 1 million cytology exams, 200,000 biopsies, and 60,000+ molecular-pathology tests annually, supported by AI-augmented workflows (Hologic Genius, IBEX) and the proprietary WebZIS results portal. Services are delivered to Czech clinicians and hospitals under contracts with public health insurers, with a parallel self-pay channel for consumers via dedicated websites.

Product overview

Bioptická laboratoř s.r.o. is a large, integrated diagnostic pathology laboratory — not a single SaaS product but a portfolio of specialized diagnostic service modules supported by digital platforms. The core offerings comprise Biopsie (with on-site Immunohistochemistry), Cytologie (including Liquid Based Cytology with AI-assisted Genius evaluation), Molekulární genetika a mikrobiologie (molecular genetics and microbiology/virology), Dermatopatologie, and HPV testing. These core diagnostic services are complemented by named products/modules: WebZIS (online results portal), the PANORAMA® NIPT non-invasive prenatal test, ZjistiCoTiJe.cz (direct-to-consumer lab test ordering website), Diagnostika autoimunitních bulózních onemocnění (autoimmune bullous disease diagnostics using Euroimun ELISA), Diagnostika koronaviru SARS-CoV-2 (NGS-based coronavirus sequencing and antibody testing), and Vyšetření genetické predispozice karcinomu prsu (hereditary cancer genetic predisposition testing). Two accredited training centers — the ICDP-UEMS Dermatopathology Training Center and the ESP Genitourinary Pathology Training Center (Giordano Fellowship) — extend the offering into medical education. AI capability is embedded in the cytology workflow via the Hologic Genius system and in prostate biopsy interpretation via the IBEX AI program.

Differentiator

Problem solved

Functional benefit

Products and services

• Biopsie (Biopsy examinations) Complete biopsy diagnostic service with direct follow-up to immunohistochemical and necessary molecular genetic examinations for referring Czech clinicians and hospitals; approximately 200,000 biopsy samples processed annually.
• Cytologie (Cytology with LBC and AI-assisted Hologic Genius) Investigation of gynecological cytology (oncological and functional examinations of smears from the cervix, vaginal mucosa, vulva and endometrium) and non-gynecological cytology; approximately 1,000,000 cytological examinations processed annually, differentiated by Liquid Based Cytology (LBC) with Hologic Genius AI evaluation.
• Imunohistochemie (Immunohistochemistry) Immunohistochemical examinations carried out under a flexible scope of accreditation granted by the Czech Institute for Accreditation (ČIA), providing direct follow-up to biopsy examinations and supporting tumor classification.
• Molekulární genetika a mikrobiologie (Molecular genetics and microbiology) Molecular genetic examinations performed on cytology and biopsy specimens in the diagnosis of tumor diseases and infectious processes; the largest Czech genetic facility focused on oncological diagnostics, performing more than 60,000 genetic and molecular-pathology tests annually including predictive oncology testing.
• Dermatopatologie (Dermatopathology) Specialized dermatopathology diagnostics staffed by European-certified specialists holding the "Diploma in Dermatopathology" from the International Committee for Dermatopathology (ICDP), including autoantibody ELISA testing for autoimmune bullous diseases.
• HPV vyšetření (HPV testing) HPV testing for cervical cancer prevention, paid by Czech public health insurers within the national screening programme as well as for self-pay patients, using Digene Hybrid Capture 2 (13 high-risk HPV types) and InnoLiPA genotyping (vaccine types 6, 11, 16, 18).
• WebZIS (online results and requisition portal) Web-based information system providing clinicians with internet access to histological and cytological examination results and enabling online requisition submission from any internet-connected device.
• PANORAMA® NIPT test (non-invasive prenatal testing) Non-invasive prenatal test (NIPT) offered using the Panorama™ test from Natera, detecting the most common fetal genetic defects from the pregnant woman's blood, available to self-paying pregnant women through a dedicated microsite.
• Diagnostika autoimunitních bulózních onemocnění (Autoimmune bullous disease diagnostics) IgG autoantibody testing from blood by ELISA using a certified Euroimmun kit covering 6 antigens (BP180, BP230, desmoglein 1, desmoglein 3, envoplakin, collagen VII) plus IgA antibodies against gliadin for dermatitis herpetiformis, complementing direct immunofluorescence for autoimmune bullous disease diagnostics.
• Diagnostika SARS-CoV-2 (SARS-CoV-2 PCR/antigen/antibody testing and NGS genome sequencing) SARS-CoV-2 PCR, antigen and antibody testing for self-pay patients (including travelers) plus routine NGS-based whole-genome sequencing of positive samples to identify viral mutations and assign lineages.
• Vyšetření genetické predispozice k nádorovým onemocněním (Hereditary cancer predisposition testing) Genetic testing of inherited predisposition to hereditary cancer (e.g., breast cancer) for self-pay patients, offered through a dedicated microsite (dedicne.nadory.cz).
• ZjistiCoTiJe.cz (direct-order self-pay lab testing storefront) Self-pay e-commerce website allowing Czech consumers to order selected laboratory examinations (HPV genotyping, Panorama NIPT, hereditary cancer panels, others) without a doctor's requisition.
• ICDP-UEMS Dermatopathology Training Center EU-accredited specialty training center offering multi-week/month fellowships in dermatopathology at the Rejskova "Eden" facility, attracting international trainees and supporting second-opinion consultations.
• ESP Genitourinary Pathology Training Center (Giordano Fellowship) ESP-accredited specialty training center offering genitourinary pathology training and fellowships, coordinated with the European Society of Pathology and listed on the ESP webpage.
• Monografie "Nádory varlat" (Testicular Tumors monograph) Expert Czech-language monograph on testicular tumors providing latest findings, practical procedures and recommendations in histopathology and oncology, distributed by Bioptická laboratoř for 599 CZK per copy.

Segments7 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability3 records

Feature6 records

Partnerships

18 partnerships are on record, tiered flagship — explicit czech–taiwan memorandum for joint ai diagnostic program development, core — underpins cervical cancer screening ai strategy, core — used for all thin-needle prostate biopsies read at the lab, supporting, supporting — sole hpv testing platform reimbursed by czech insurers, supporting — hpv genotyping platform for self-pay patients, core — primary non-invasive prenatal testing offering, flagship — esp-accredited giordano fellowship training center, flagship — eu-accredited dermatopathology training center and flagship — joint clinical-academic pathology operation.

• AIxMedflagship — explicit czech–taiwan memorandum for joint ai diagnostic program developmentStrategic or Co-development Partner · 2 June 2026Memorandum of cooperation signed on 2 June 2026 in Taiwan by doc. MUDr. Michael Michal, Ph.D. and MUDr. Robert Slunéčko (Bioptická laboratoř) with AIxMed (Taiwanese software firm). Defines framework for future co-development of additional AI-powered diagnostic programs and broader deployment of digital tools in healthcare.
• Hologic (Genius AI system)core — underpins cervical cancer screening ai strategyTechnology or IntegrationHologic provides the Genius AI system for cervical cytology evaluation, including 2 scanners (~€1M each) and 6 reading stations (~€50,000 each) with EMA and FDA certification. Press release issued via Hologic's Czech distributor Biomedica. Hologic planned an additional AI version for urinary cytology at end of 2024.
• IBEX (prostate biopsy AI)core — used for all thin-needle prostate biopsies read at the labTechnology or IntegrationIBEX AI program deployed in June 2024 to read all thin-needle prostate biopsies, materially reducing missed small adenocarcinomas. Demoed at the IBEX booth during the 6th Urogenital Pathology Meeting (KTF 2024, Mikulov 13–15 June 2024); doc. Pivovarčíková lectured on the topic.
• Biomedica (Hologic distributor for Czech Republic)supportingChannel Partner/ Reseller/ DistributorLocal Czech distributor of Hologic; co-issued the Genius press release announcing the AI cytology deployment at Bioptická laboratoř.
• Digene (Qiagen) — Hybrid Capture 2supporting — sole hpv testing platform reimbursed by czech insurersOEM/ Whitelabel/ Licensing PartnerHybrid Capture 2 platform used for the 13 high-risk HPV types detection covered by Czech health insurance for cervical cancer screening triage.
• Innogenetics — InnoLiPAsupporting — hpv genotyping platform for self-pay patientsOEM/ Whitelabel/ Licensing PartnerInnoLiPA HPV genotyping platform (individual types including vaccine types 6, 11, 16, 18) used for self-pay HPV testing.
• EuroimunsupportingOEM/ Whitelabel/ Licensing PartnerEuroimun certified ELISA kit used since June 2021 for IgG autoantibody testing in autoimmune bullous diseases, complementing direct immunofluorescence.
• Panorama (Natera) — NIPTcore — primary non-invasive prenatal testing offeringOEM/ Whitelabel/ Licensing PartnerPanorama non-invasive prenatal test offered through a dedicated microsite panoramatest.cz; described by the lab as the most reliable NIPT globally.
• European Society of Pathology (ESP)flagship — esp-accredited giordano fellowship training centerStrategic or Co-development PartnerESP awarded the lab's Šikl's Department of Pathology accreditation as ESP Advanced Training Centre "Giordano Fellowship" in 2015 for Genitourinary Pathology training; program coordinated with the ESP and listed on the ESP webpage.
• International Committee for Dermatopathology / UEMS (ICDP-UEMS)flagship — eu-accredited dermatopathology training centerStrategic or Co-development PartnerICDP-UEMS accreditation as Specialty Training Centre in Dermatopathology — granted to Bioptická laboratoř s.r.o. in 2012 and to the Šikl Department of Pathology in 2014. Co-organizers of trainee symposia and histopathology internships at the Rejskova "Eden" facility.
• European Bone Marrow Working Group (EBMWG)supportingStrategic or Co-development PartnerHosted the EBMWG 2019 Scientific and Business Meeting (25–26 October 2019) at Rejskova 10, Pilsen; local organizer was Ludmila Boudová.
• Šikl's Department of Pathology, University Hospital and Medical Faculty of Charles University in Pilsenflagship — joint clinical-academic pathology operationStrategic or Co-development PartnerLong-standing institutional collaboration with Charles University's Šikl's Department of Pathology; co-accredited training sites, joint scientific programs, and co-hosted conferences including BST 2025 (course director Michael Michal, joint affiliation).
• Lékařská fakulta Univerzity Karlovy v Plzni (Charles University Faculty of Medicine in Pilsen)supportingStrategic or Co-development PartnerAcademic affiliation for Ph.D. students (e.g., Antonina Kalmykova) and joint educational/research activities.
• BioTech, Baria, Altium — BST 2025 industry partners/sponsorssupportingGTM or Marketing PartnerIndustry sponsors of the 1st Bone and Soft Tissue Pathology Meeting (February 2025, Pilsen); logos displayed on meeting materials.
• Arkadi M. Rywlin International Pathology Slide Seminar ClubsupportingStrategic or Co-development PartnerCo-organizer of the 2nd (Srni 2005) and 13th (Pilsen 16–18 June 2025) Arkadi M. Rywlin International Pathology Slide Symposium in Anatomic Pathology.
• Kidney Tumor Friends (KTF)supportingStrategic or Co-development PartnerCo-organizes the Urogenital Pathology Meetings (3rd 2014 Mikulov, 5th 2021 Pilsen, 6th 2024 Mikulov) in honour of Prof. Ondřej Hes, founder of KTF.
• Association of Clinical Pathologists (ACP)supportingStrategic or Co-development PartnerSponsored the ACP Histopathology Courses in Pilsen (February 2008).
• Protext (ČTK press release service)supportingGTM or Marketing PartnerPress release distribution partner (used for the 8 July 2024 Biomedica × Bioptická Laboratoř Genius AI announcement).

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bioptickalaborator

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioptická laboratoř